Sequent Scien. Financials Statement

FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	Sep-2023	Jun-2023	Mar-2023	Dec-2022	Sep-2022
Gross Sales	345.97	333.21	366.67	375.31	337.61
Excise Duty	--	--	--	--	--
Net Sales	345.97	333.21	366.67	375.31	337.61
Other Operating Income	--	--	--	--	--
Other Income	9.72	0.79	1.74	2.86	0.91
Total Income	355.68	334	368.41	378.18	338.52
Total Expenditure	330.84	364.96	431.63	364.98	334.74
PBIDT	24.85	(30.95)	(63.23)	13.20	3.78
Interest	12.58	10.48	10.87	9.73	8.12
PBDT	12.27	(41.44)	(74.10)	3.48	(4.34)
Depreciation	15.36	14.24	14.71	13.67	13.38
Minority Interest Before NP	--	--	--	--	--
Tax	17.67	(11.70)	4.91	(0.40)	3.83
Deferred Tax	(13.88)	(9.30)	(1.27)	(0.02)	(17.11)
Reported Profit After Tax	(6.88)	(34.68)	(92.44)	(9.78)	(4.44)
Minority Interest After NP	1.50	0.17	1.14	(0.91)	(0.69)
Net Profit after Minority Interest	(8.38)	(34.85)	(93.57)	(8.87)	(3.75)
Extra-ordinary Items	(9.60)	(23.51)	(58.19)	--	--
Adjusted Profit After Extra-ordinary item	1.22	(11.34)	(35.38)	(8.87)	(3.75)
EPS (Unit Curr.)	(0.34)	(1.40)	(3.77)	(0.36)	(0.15)
Book Value (Unit Curr.)	--	--	--	--	--
Dividend (%)	--	--	--	--	--
Equity	49.89	49.89	49.89	49.89	49.89
Public Shareholding (Number)	--	--	--	--	--
Public Shareholding (%)	--	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--	--
PBIDTM(%)	7.18	(9.29)	(17.24)	3.52	1.12
PBDTM(%)	3.55	(12.44)	(20.21)	0.93	(1.29)
PATM(%)	(1.99)	(10.41)	(25.21)	(2.61)	(1.31)

QuickLinks for Sequent Scientific Ltd.